About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 23 Issue 7 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2232 results:

Case report

Optimizing concentrations of concomitant antiretrovirals by reducing etravirine doses: two case reports of complex drug–drug interactions

Jean-Simon Denault, Jean-François Cabot, Hugo Langlois, Suzanne Marcotte, Nancy L Sheehan

Antiviral Therapy 2019; 24:73-76


Free
Short communication

Increased dose of dolutegravir as a potential rescue therapy in multi-experienced patients

Davide Ferrari, Vincenzo Spagnuolo, Monica Manca, Alba Bigoloni, Camilla Muccini, Giuseppe Banfi, Massimo Locatelli, Antonella Castagna

Antiviral Therapy 2019; 24:69-72


Short communication

A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients

Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, Stefano Rusconi, Gaetana Sterrantino, Gabriella d’Ettorre, Manuela Colafigli, Sara Modica, Filippo Lagi, Andrea Giacomelli, Maria Vittoria Cossu, Sibilla Restelli, Andrea De Luca, Simona Di Giambenedetto

Antiviral Therapy 2019; 24:63-67


Original article

Frailty as a predictor of falls in HIV-infected and uninfected women

Anjali Sharma, Donald R Hoover, Qiuhu Shi, Deborah R Gustafson, Michael W Plankey, Phyllis C Tien, Kathleen M Weber, Michael T Yin

Antiviral Therapy 2019; 24:51-61


Free
Original article

Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tract

Julie B Dumond, Stephen A Greene, Heather MA Prince, Jingxian Chen, Brian M Maas, Craig Sykes, Amanda P Schauer, Kimberly H Blake, Julie AE Nelson, Cynthia L Gay, Angela DM Kashuba, Myron S Cohen

Antiviral Therapy 2019; 24:45-50


Free
Original article

Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)

Fred Poordad, Mitchell L Shiffman, Wayne Ghesquiere, Alexander Wong, Gregory D Huhn, Florence Wong, Alnoor Ramji, Stephen D Shafran, Fiona McPhee, Rong Yang, Stephanie Noviello, Misti Linaberry, the ALLY-3C study team

Antiviral Therapy 2019; 24:35-44


Original article

Autophagy involved in antiviral activity of sodium tanshinone IIA sulfonate against porcine reproductive and respiratory syndrome virus infection in vitro

Na Sun, Panpan Sun, Mingjie Yao, Ajab Khan, Yaogui Sun, Kuohai Fan, Wei Yin, Hongquan Li

Antiviral Therapy 2019; 24:27-33


Free
Original article

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting

Farah Ladak, Eugenia Socias, Seonaid Nolan, Huiru Dong, Thomas Kerr, Evan Wood, Julio Montaner, M-J Milloy

Antiviral Therapy 2019; 24:19-25


Original article

Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV–HIV-coinfected patients

Ana D Vega, Lauren M Hynicka, Kimberly Claeys, Joel V Chua, Emily L Heil

Antiviral Therapy 2019; 24:11-17


Review

Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patients

Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson

Antiviral Therapy 2019; 24:1-10


Page:
Copyright © 2019 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.